Walker Karen Marie 4
4 · Kyverna Therapeutics, Inc. · Filed Jun 10, 2024
Insider Transaction Report
Form 4
Walker Karen Marie
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2024-06-06$4.42/sh+9,636$42,591→ 9,636 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-06-06−9,636→ 82,648 totalExercise: $4.42→ Common Stock (9,636 underlying)
Footnotes (1)
- [F1]25% of the original number of shares subject to the option vested on September 13, 2022, and 1/48th of the original number of shares subject to the option vested or shall vest in monthly installments thereafter.